MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study

Diabetologia

Volumn 59, Issue 9, 2016, Pages 1882-1892

  von Toerne, Christine ^a,b   Huth, Cornelia ^a,b   de las Heras Gala, Tonia ^a   Kronenberg, Florian ^c   Herder, Christian ^b,d   Koenig, Wolfgang ^e,f,g   Meisinger, Christa ^a,b,h   Rathmann, Wolfgang ^b,i   Waldenberger, Melanie ^a   Roden, Michael ^b,d,i   Peters, Annette ^a,b   Thorand, Barbara ^a,b   Hauck, Stefanie M ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^h KLINIKUM AUGSBURG   (Germany)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Epidemiology; Prediction and prevention of type 2 diabetes; Proteomics

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN C2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLPD1 PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MANNAN BINDING LECTIN SERINE PEPTIDASE 1; RETINOL BINDING PROTEIN 4; THROMBOSPONDIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; GLYCOSYLPHOSPHATIDYLINOSITOL PHOSPHOLIPASE D; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MASP1 PROTEIN, HUMAN; PHOSPHOLIPASE D; THROMBOSPONDIN; THROMBOSPONDIN 2;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PROTEOMICS; SMOKING; METABOLISM; MIDDLE AGED;

AGED; APOLIPOPROTEINS A; BIOMARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; PHOSPHOLIPASE D; PREDIABETIC STATE; PROTEOMICS; THROMBOSPONDINS;

EID: 84976320580     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-4024-2     Document Type: Article

References (46)

1. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379:2279–2290
2. Huth C, Beuerle S, Zierer A et al (2015) Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study. Eur J Endocrinol 173:643–653
3. Kluppelholz B, Thorand B, Koenig W et al (2015) Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study. Diabetologia 58:2269–2277
4. Herder C, Karakas M, Koenig W (2011) Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 90:52–66
5. Herder C, Kowall B, Tabak AG, Rathmann W (2014) The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia 57:16–29
6. Shao S, Guo T, Aebersold R (2015) MS-based proteomic quest for diabetes biomarkers. Biochim Biophys Acta 1854:519–527
7. Wang-Sattler R, Yu Z, Herder C et al (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 8:615
8. Yokoi N, Beppu M, Yoshida E et al (2015) Identification of putative biomarkers for prediabetes by metabolome analysis of rat models of type 2 diabetes. Metabolomics 11:1277–1286
9. Marx V (2013) Targeted proteomics. Nat Methods 10:19–22
10. Picotti P, Bodenmiller B, Aebersold R (2013) Proteomics meets the scientific method. Nat Methods 10:24–27
11. Gillette MA, Carr SA (2013) Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods 10:28–34
12. von Toerne C, Kahle M, Schafer A et al (2013) Apoe, Mbl2, and Psp plasma protein levels correlate with diabetic phenotype in NZO Mice – an optimized rapid workflow for SRM-based quantification. J Proteome Res 12:1331–1343
13. Rathmann W, Kowall B, Tamayo T et al (2012) Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med 44:170–177
14. Ruckert IM, Heier M, Rathmann W, Baumeister SE, Doring A, Meisinger C (2011) Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study. PLoS One 6:e22932
15. Stangl S, Kollerits B, Lamina C et al (2015) Association between apolipoprotein A-IV concentrations and chronic kidney disease in two large population-based cohorts: results from the KORA studies. J Intern Med 278:410–423
16. Meisinger C, Ruckert IM, Rathmann W et al (2011) Retinol-binding protein 4 is associated with prediabetes in adults from the general population: the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes Care 34:1648–1650
17. WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation Part 1: Diagnosis and classification of diabetes mellitus. WHO Department of Noncommunicable Disease Surveillance, Geneva, pp 1–59
18. MacLean B, Tomazela DM, Shulman N et al (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966–968
19. R Development Core Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, available from www.r-project.org/
20. Abbatiello SE, Mani DR, Keshishian H, Carr SA (2010) Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring MS. Clin Chem 56:291–305
21. Mani DR, Abbatiello SE, Carr SA (2012) Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics. BMC Bioinformatics 13(Suppl 16):S9
22. Thiel S (2007) Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 44:3875–3888
23. Dobo J, Schroeder V, Jenny L, Cervenak L, Zavodszky P, Gal P (2014) Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation. Mol Immunol 61:69–78
24. Frauenknecht V, Thiel S, Storm L et al (2013) Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases. Clin Exp Immunol 173:112–120
25. Sildorf SM, Eising S, Hougaard DM et al (2014) Differences in MBL levels between juvenile patients newly diagnosed with type 1 diabetes and their healthy siblings. Mol Immunol 62:71–76
26. Bouwman LH, Eerligh P, Terpstra OT et al (2005) Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. Diabetes 54:3002–3006
27. Hansen TK, Thiel S, Knudsen ST et al (2003) Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab 88:4857–4861
28. Hansen TK, Tarnow L, Thiel S et al (2004) Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 53:1570–1576
29. Fernandez-Real JM, Straczkowski M, Vendrell J et al (2006) Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin. Diabetologia 49:2402–2411
30. Jenny L, Ajjan R, King R, Thiel S, Schroeder V (2015) Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control. Clin Exp Immunol 180:227–232
31. Fortpied J, Vertommen D, Van Schaftingen E (2010) Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev 26:254–260
32. Hoener MC, Brodbeck U (1992) Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins. Eur J Biochem 206:747–757
33. Schofield JN, Stephens JW, Hurel SJ, Bell KM, deSouza JB, Rademacher TW (2002) Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats. Mol Genet Metab 75:154–161
34. Suzuki S, Suzuki C, Hinokio Y et al (2014) Insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity. PLoS One 9:e100466
35. Green PH, Glickman RM, Riley JW, Quinet E (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 65:911–919
36. Ezeh B, Haiman M, Alber HF et al (2003) Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls. J Lipid Res 44:1523–1529
37. Wang F, Kohan AB, Lo CM, Liu M, Howles P, Tso P (2015) Apolipoprotein A-IV: a protein intimately involved in metabolism. J Lipid Res 56:1403–1418
38. Maritim AC, Sanders RA, Watkins JB 3rd (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24–38
39. Hellstrom PM (2013) Satiety signals and obesity. Curr Opin Gastroenterol 29:222–227
40. Wang F, Kohan AB, Kindel TL et al (2012) Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proc Natl Acad Sci U S A 109:9641–9646
41. Pressler JW, Haller A, Sorrell J et al (2015) Vertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice. Diabetes 64:498–507
42. Verges B (1995) Apolipoprotein A-IV in diabetes mellitus. Diabete Metab 21:99–105
43. Sun Z, Larson IA, Ordovas JM, Barnard JR, Schaefer EJ (2000) Effects of age, sex, and lifestyle factors on plasma apolipoprotein A-IV concentrations. Atherosclerosis 151:381–388
44. Kong P, Cavalera M, Frangogiannis NG (2014) The role of thrombospondin (TSP)-1 in obesity and diabetes. Adipocytes 3:81–84
45. Varma V, Yao-Borengasser A, Bodles AM et al (2008) Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 57:432–439
46. Kong P, Gonzalez-Quesada C, Li N, Cavalera M, Lee DW, Frangogiannis NG (2013) Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Am J Physiol Endocrinol Metab 305:E439–E450